All Stories

  1. Correction: Challenge accepted: Uncovering the role of rare genetic variants in Alzheimer’s disease
  2. Whole-exome sequencing reveals PSEN1 and ATP7B combined variants as a possible cause of early-onset Lewy body dementia: a case study of genotype–phenotype correlation
  3. Molecular Characterization of Portuguese Patients with Hereditary Cerebellar Ataxia
  4. Challenge accepted: uncovering the role of rare genetic variants in Alzheimer’s disease
  5. Genetic variants in glutamate, Aβ and tau related pathways determine polygenic risk for Alzheimer’s disease
  6. Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers
  7. KCNN2 mutation in autosomal‐dominant tremulous myoclonus‐dystonia
  8. Genetic architecture of common non-Alzheimer’s disease dementias
  9. Novel MAG Variant Causes Cerebellar Ataxia with Oculomotor Apraxia: Molecular Basis and Expanded Clinical Phenotype
  10. Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia
  11. Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information
  12. Alzheimer’s Disease Genetics: Review of Novel Loci Associated with Disease
  13. A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC‐derived microglia
  14. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study
  15. Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies
  16. Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score
  17. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
  18. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
  19. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
  20. Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson’s disease
  21. An AARS variant as the likely cause of Swedish type hereditary diffuse leukoencephalopathy with spheroids
  22. Two pathologically confirmed cases of novel mutations in the MAPT gene causing frontotemporal dementia
  23. The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population‐Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight
  24. A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC--derived microglia
  25. Heritability and genetic variance of dementia with Lewy bodies
  26. Education modulates brain maintenance in presymptomatic frontotemporal dementia
  27. Alzheimer’s disease polygenic risk score as a predictor of conversion from mild-cognitive impairment
  28. Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia
  29. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability
  30. The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint
  31. A comprehensive screening of copy number variability in dementia with Lewy bodies
  32. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
  33. The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
  34. Peripheral GRN mRNA and Serum Progranulin Levels as a Potential Indicator for Both the Presence of Splice Site Mutations and Individuals at Risk for Frontotemporal Dementia
  35. LRP10 in α-synucleinopathies
  36. LRP10 in α-synucleinopathies
  37. Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease
  38. Heritability and genetic variance of dementia with Lewy bodies
  39. Is APOE ε4 required for Alzheimer's disease to develop in TREM2 p.R47H variant carriers?
  40. AP4S1 splice-site mutation in a case of spastic paraplegia type 52 with polymicrogyria
  41. The Genetics of Dementia with Lewy Bodies: Current Understanding and Future Directions
  42. The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders
  43. A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease
  44. Analysis of shared heritability in common disorders of the brain
  45. Genotyping of the Alzheimer’s Disease Genome-Wide Association Study Index Single Nucleotide Polymorphisms in the Brains for Dementia Research Cohort
  46. Mendelian adult-onset leukodystrophy genes in Alzheimer's disease: critical influence of CSF1R and NOTCH3
  47. A comprehensive assessment of benign genetic variability for neurodegenerative disorders
  48. Genetics of dementia in a Finnish cohort
  49. Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease
  50. An Aged Canid with Behavioral Deficits Exhibits Blood and Cerebrospinal Fluid Amyloid Beta Oligomers
  51. Late-onset and acute presentation of Brown-Vialetto-Van Laere syndrome in a Brazilian family
  52. Whole-exome sequencing of the BDR cohort: evidence to support the role of the PILRA gene in Alzheimer's disease
  53. Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study
  54. Adenosine Deaminase Two and Immunoglobulin M Accurately Differentiate Adult Sneddon’s Syndrome of Unknown Cause
  55. The genetic landscape of Alzheimer disease
  56. Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience
  57. A recessive ataxia diagnosis algorithm for the next generation sequencing era
  58. Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease
  59. Mutations in TYROBP are not a common cause of dementia in a Turkish cohort
  60. NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases
  61. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
  62. Multi-infarct dementia of Swedish type is caused by a 3’UTR mutation of COL4A1
  63. No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson’s disease in nine ADHD candidate SNPs
  64. Discovery and functional prioritization of Parkinson’s disease candidate genes from large-scale whole exome sequencing
  65. Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies
  66. Mutation analysis of sporadic early-onset Alzheimer's disease using the NeuroX array
  67. Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer’s disease: a case series
  68. TYROBP genetic variants in early-onset Alzheimer's disease
  69. CLN8 disease caused by large genomic deletions
  70. Exome sequencing in a consanguineous family clinically diagnosed with early-onset Alzheimer's disease identifies a homozygous CTSF mutation
  71. Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients
  72. Pseudohypoparathyroidism type I-b with neurological involvement is associated with a homozygousPTH1Rmutation
  73. Influence of Coding Variability in APP-Aβ Metabolism Genes in Sporadic Alzheimer’s Disease
  74. Mutation ofTBCKcauses a rare recessive developmental disorder
  75. The phenotypic spectrum of Schaaf-Yang syndrome: 18 new affected individuals from 14 families
  76. RARS2mutations in a sibship with infantile spasms
  77. ABCA7 p.G215S as potential protective factor for Alzheimer's disease
  78. Characterization of an FTLD-PDB family with the coexistence of SQSTM1 mutation and hexanucleotide (G 4 C 2 ) repeat expansion in  C9orf72 gene
  79. Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy
  80. Screening exons 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer's disease
  81. The clinical syndrome of dystonia with anarthria/aphonia
  82. Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases
  83. The Chihuahua dog: A new animal model for neuronal ceroid lipofuscinosis CLN7 disease?
  84. A Novel MAPT Mutation Causing Corticobasal Syndrome Led by Progressive Apraxia of Speech
  85. Common polygenic variation enhances risk prediction for Alzheimer’s disease
  86. The age factor in Alzheimer’s disease
  87. A systematic screening to identifyde novomutations causing sporadic early-onset Parkinson's disease
  88. Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study
  89. Loss-of-function mutations inRAB39Bare associated with typical early-onset Parkinson disease
  90. Quantitative Interaction Proteomics of Neurodegenerative Disease Proteins
  91. A novel Alzheimer disease locus located near the gene encoding tau protein
  92. Mutations in PNKP Cause Recessive Ataxia with Oculomotor Apraxia Type 4
  93. NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases
  94. SnapShot: Genetics of ALS and FTD
  95. SnapShot: Genetics of Parkinson’s Disease
  96. H-ABC syndrome and DYT4: Variable expressivity or pleiotropy of TUBB4 mutations?
  97. Genetic Variants and Related Biomarkers in Sporadic Alzheimer’s Disease
  98. Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease
  99. A Phenotype of Atypical Apraxia of Speech in a Family Carrying SQSTM1 Mutation
  100. A nonsense mutation in PRNP associated with clinical Alzheimer's disease
  101. Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption
  102. Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease
  103. Homozygous TREM2 mutation in a family with atypical frontotemporal dementia
  104. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia
  105. Genetics of Alzheimer’s Disease
  106. Mutant ADA2 in Vasculopathies
  107. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
  108. Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies
  109. Missense variant in TREML2 protects against Alzheimer's disease
  110. Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease
  111. Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations
  112. Atypical Parkinsonism-Dystonia Syndrome Caused by a Novel DJ1 Mutation
  113. Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease
  114. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease
  115. A Paired RNAi and RabGAP Overexpression Screen Identifies Rab11 as a Regulator of β-Amyloid Production
  116. Insights into TREM2 biology by network analysis of human brain gene expression data
  117. A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family
  118. A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease
  119. CLN6 disease caused by the same mutation originating in Pakistan has varying pathology
  120. SnapShot: Genetics of Alzheimer’s Disease
  121. TREM2and Neurodegenerative Disease
  122. NOTCH3 Variants and Risk of Ischemic Stroke
  123. Genetic comorbidities in Parkinson's disease
  124. SQSTM1Mutations in French Patients With Frontotemporal Dementia or Frontotemporal Dementia With Amyotrophic Lateral Sclerosis
  125. A novel A781V mutation in the CSF1R gene causes hereditary diffuse leucoencephalopathy with axonal spheroids
  126. Analysis of Genome-Wide Association Studies of Alzheimer Disease and of Parkinson Disease to Determine If These 2 Diseases Share a Common Genetic Risk
  127. Genetic Analysis of Inherited Leukodystrophies
  128. Serum Iron Levels and the Risk of Parkinson Disease: A Mendelian Randomization Study
  129. Linking Protective GAB2 Variants, Increased Cortical GAB2 Expression and Decreased Alzheimer’s Disease Pathology
  130. Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease
  131. The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism
  132. Initial Assessment of the Pathogenic Mechanisms of the Recently Identified Alzheimer Risk Loci
  133. TREM2 Variants in Alzheimer's Disease
  134. Using Exome Sequencing to Reveal Mutations in TREM2 Presenting as a Frontotemporal Dementia–like Syndrome Without Bone Involvement
  135. A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease
  136. A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer's disease risk
  137. TOMM40 Association With Alzheimer Disease
  138. Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease
  139. Use of support vector machines for disease risk prediction in genome-wide association studies: Concerns and opportunities
  140. Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients
  141. Genetic testing in familial and young-onset Alzheimer's disease: mutation spectrum in a Serbian cohort
  142. Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease
  143. Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease
  144. Tau acts as an independent genetic risk factor in pathologically proven PD
  145. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study
  146. Screening for VPS35 mutations in Parkinson's disease
  147. Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis
  148. The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE
  149. Identification of Stk25 as a Genetic Modifier of Tau Phosphorylation in Dab1-Mutant Mice
  150. Complement receptor 1 (CR1) and Alzheimer's disease
  151. Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series
  152. The Role of Variation at AβPP, PSEN1, PSEN2, and MAPT in Late Onset Alzheimer's Disease
  153. Clusterin as an Alzheimer Biomarker
  154. Genome-wide association study of Alzheimer's disease with psychotic symptoms
  155. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
  156. Alzheimer's disease genetics: lessons to improve disease modelling
  157. A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease
  158. A new way APP mismetabolism can lead to Alzheimer's disease
  159. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
  160. Correction: Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
  161. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies
  162. Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
  163. Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p
  164. PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit
  165. Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP
  166. Genetic Variability in CLU and Its Association with Alzheimer's Disease
  167. A thorough assessment of benign genetic variability inGRNandMAPT
  168. A Case of Dementia With PRNP D178Ncis-129M and No Insomnia
  169. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
  170. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal
  171. Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration
  172. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
  173. TDP-43 Is Not a Common Cause of Sporadic Amyotrophic Lateral Sclerosis
  174. Novel progranulin mutation: Screening for PGRN mutations in a Portuguese series of FTD/CBS cases
  175. DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA
  176. Genotype, haplotype and copy-number variation in worldwide human populations
  177. Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2
  178. Peripheral Inflammatory Cytokines as Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment
  179. Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort
  180. G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort